Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuyuekang Capsules (妇月康胶囊) is a traditional Chinese medicine (TCM) oral formulation developed and manufactured by Jilin Province Oriental Pharmaceutical. It is primarily indicated for the treatment of postpartum conditions, including persistent lochia, abdominal pain due to blood stasis, and incomplete uterine involution. The medication is also used for various gynecological conditions characterized by blood stasis. Its therapeutic action is based on traditional principles of invigorating blood and transforming stasis, which clinically translates to promoting uterine contractions and reducing inflammation and pain following childbirth or miscarriage. It is an approved pharmaceutical product in China, commonly utilized to support recovery in the postpartum period.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fuyuekang Capsules.